FIELD: abdominal surgery.
SUBSTANCE: 15-20 ml of 5-7,5% solution of phospholipids are introduced into operational zone.
EFFECT: prevented commissure formation.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING THE CASES OF COMMISSURE DISEASE | 1998 |
|
RU2177741C2 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF PARTIAL AND FULL ADHESIVE MECHANICAL SMALL BOWEL OBSTRUCTION AT CHILDREN BY MEANS OF ECHOGRAPHY | 2007 |
|
RU2337621C2 |
| METHOD FOR ASSESSING THE SEVERITY OF ADHESION PROCESS IN THE ABDOMINAL CAVITY | 2017 |
|
RU2661727C1 |
| METHOD FOR PREVENTION OF RECURRENT LAPSE OF POSTOPERATIVE ABDOMINAL ADHESIONS | 2009 |
|
RU2393865C1 |
| METHOD OF PREVENTION OF COMMISSURE FORMATION AND RELAPSE THEREOF | 2007 |
|
RU2331367C1 |
| METHOD FOR TREATING ADHESION DISEASE OF ABDOMINAL CAVITY | 2003 |
|
RU2239397C1 |
| METHOD OF PREVENTION OF INTRAPERITONEAL POSTOPERATIVE ADHESIONS | 2018 |
|
RU2673380C1 |
| CHERSY - G GUDIYEV'S METHOD FOR PREVENTION OF DEVELOPING POSTOPERATIVE ABDOMINAL ADHESION PROCESS | 2011 |
|
RU2477993C2 |
| METHOD OF ADHESION THERAPY FOLLOWING THORACIC AND ABDOMINAL ORGANS SURGERY | 2006 |
|
RU2348415C2 |
| METHOD OF TREATING RECURRENT ADHESIVE INTESTINAL OBSTRUCTION | 2023 |
|
RU2821135C1 |
